Progranulin stimulated by LPA promotes the migration of aggressive breast cancer cells

Cell Communication and Adhesion

Volumn 18, Issue 6, 2011, Pages 119-130

  Swamydas, Muthulekha ^a   Nguyen, Do ^a   Allen, Lauren D ^a   Eddy, Jill ^a   Dréau, Didier ^a  

^a UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

Author keywords

LPA; lysophosphatidic acid; MAPK; mitogen activated protein kinase; PGRN; progranulin

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTIBODY; ANTINEOPLASTIC AGENT; FOCAL ADHESION KINASE; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR 1; LYSOPHOSPHATIDIC ACID RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE; PROGRANULIN; PROGRANULIN ANTIBODY; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER INVASION; CELL MIGRATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 84855400983     PISSN: 15419061     EISSN: 15435180     Source Type: Journal    
DOI: 10.3109/15419061.2011.641042     Document Type: Article

References (61)

1. Aoki J, Inoue A, Okudaira S (2008). Two pathways for lysophosphatidic acid production. Biochim Biophys Acta. 1781: 513-518.
2. Bateman A, Bennett HP (2009). The granulin gene family: from cancer to dementia. Bioessays. 31: 1245-1254.
3. Boucharaba A, Serre CM, Guglielmi J, Bordet JC, Clezardin P, Peyruchaud O (2006). The type 1 lysophosphatidic acidreceptor is a target for therapy in bone metastases. Proc Natl Acad Sci U S A. 103: 9643-9648. (Pubitemid 43955878)
4. Braddock DT (2010). Autotaxin and lipid signaling pathways as anticancer targets. Curr Opin Investig Drugs. 11: 629-637.
5. Buist A, Tertoolen LG, Den Hertog J (1998). Potentiation of G-protein-coupled receptor-induced MAP kinase activation by exogenous EGF receptors in SK-N-MC neuroepithelioma cells. Biochem Biophys Res Comm. 251: 6-10. (Pubitemid 28498054)
6. Chen HW, Lee JY, Huang JY, Wang CC, Chen WJ, Su SF, Huang CW, Ho CC, Chen JJ, Tsai MF, Yu SL, Yang PC (2008a). Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1. Cancer Res. 68: 7428-7438.
7. Chen J, Baydoun AR, Xu R, Deng L, Liu X, Zhu W, Shi L, Cong X, Hu S, Chen X (2008b). Lysophosphatidic acid protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis. Stem Cell. 26: 135-145.
8. Chen M, Towers LN, O ' Connor KL (2007). LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower effi cacy than LPA1 (EDG2) in breast carcinoma cells. Am J Physiol Cell Physiol. 292: C1927-C1933. (Pubitemid 47080564)
9. Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, Mutoh T, Lin ME, Teo ST, Park KE, Mosley AN, Chun J (2010). LPA receptors: subtypes and biological actions. Annu Rev Pharmacol Toxicol. 50: 157-186.
10. Cuevas-Antonio R, Cancino C, Arechavaleta-Velasco F, Andrade A, Barron L, Estrada I, Fernandez RL, Olguin V, Ruiz S, Imani F, Zeferino-Toquero M, Ulloa-Aguirre A, Gerton GL, Diaz-Cueto L (2010). Expression of progranulin (Acrogranin/ PCDGF/Granulin-Epithelin Precursor) in benign and malignant ovarian tumors and activation of MAPK signaling in ovarian cancer cell line. Cancer Investig. 28: 452-458.
11. De Kok JB, Roelofs RW, Giesendorf BA, Pennings JL, Waas ET, Feuth T, Swinkels DW, Span PN (2005). Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. Lab Investig. 85: 154-159. (Pubitemid 40128049)
12. Dolezalova H, Shankar G, Huang MC, Bikle DD, Goetzl EJ (2003). Biochemical regulation of breast cancer cell expression of S1P2 (Edg-5) and S1P3 (Edg-3) G protein-coupled receptors for sphingosine 1-phosphate. J Cell Biochem. 88: 732-743. (Pubitemid 36258823)
13. Donald CD, Laddu A, Chandham P, Lim SD, Cohen C, Amin M, Gerton GL, Marshall FF, Petros JA (2001). Expression of progranulin and the epithelin/granulin precursor acrogranin correlates with neoplastic state in renal epithelium. Anticancer Res. 21: 3739-3742. (Pubitemid 34229235)
14. Dréau D, Karaa A, Culberson C, Wyan H, Mckillop IH, Clemens MG (2006). Bosentan inhibits tumor vascularization and bone metastasis in an immunocompetent skin-fold chamber model of breast carcinoma cell metastasis. Clin Exp Metastasis. 23: 41-53. (Pubitemid 44576778)
15. Du J, Sun C, Hu Z, Yang Y, Zhu Y, Zheng D, Gu L, Lu X (2010). Lysophosphatidic acid induces MDA-MB-231 breast cancer cells migration through activation of PI3K/PAK1/ERK signaling. PLoS ONE. 5: e15940.
16. Eder AM, Sasagawa T, Mao M, Aoki J, Mills GB (2000). Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2. Clin Canc Res. 6: 2482-2491. (Pubitemid 30399219)
17. Elkabets M, Gifford AM, Scheel C, Nilsson B, Reinhardt F, Bray MA, Carpenter AE, Jirstrom K, Magnusson K, Ebert BL, Ponten F, Weinberg RA, Mcallister SS (2011). Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fi broblasts in mice. J Clin Investig. 121: 784-799.
18. Gloushankova NA (2008). Changes in regulation of cell-cell adhesion during tumor transformation. Biochemistry (Mosc). 73: 742-750.
19. Goetzl EJ, Dolezalova H, Kong Y, Hu YL, Jaffe RB, Kalli KR, Conover CA (1999). Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G proteincoupled receptor for lysophosphatidic acid in ovarian cancer. Cancer Res. 59: 5370-5375. (Pubitemid 29504007)
20. Guerra RR, Kriazhev L, Hernandez-Blazquez FJ, Bateman A (2007). Progranulin is a stress-response factor in fi broblasts subjected to hypoxia and acidosis. Growth Factors. 25: 280-285.
21. Hao F, Tan M, Xu X, Han J, Miller DD, Tigyi G, Cui MZ (2007). Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38alpha. Biochim Biophys Acta. 1771: 883-892. (Pubitemid 46891301)
22. He Z, Bateman A (1999). Progranulin gene expression regulates epithelial cell growth and promotes tumor growth in vivo. Cancer Res. 59: 3222-3229. (Pubitemid 29316026)
23. He Z, Bateman A (2003). Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J Mol Med. 81: 600-612. (Pubitemid 37357675)
24. He Z, Ismail A, Kriazhev L, Sadvakassova G, Bateman A (2002). Progranulin (PC-cell-derived growth factor/acrogranin) regulates invasion and cell survival. Cancer Res. 62: 5590-5596.
25. He Z, Ong CH, Halper J, Bateman A (2003). Progranulin is a mediator of the wound response. Nat Med. 9: 225-229. (Pubitemid 36227726)
26. Ho JC, Ip YC, CheungST, Lee YT, Chan KF, Wong SY, Fan ST (2008). Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma. Hepatology. 47: 1524-1532. (Pubitemid 351702736)
27. Huang MC, Graeler M, Shankar G, Spencer J, Goetzl EJ (2002). Lysophospholipid mediators of immunity and neoplasia. Biochim Biophys Acta. 1582: 161-167. (Pubitemid 34634125)
28. Jones MB, Michener CM, Blanchette JO, Kuznetsov VA, Raffeld M, Serrero G, Emmert-Buck MR, Petricoin EF, Krizman DB, Liotta LA, Kohn EC (2003). The granulinepithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer. Clin Canc Res. 9: 44-51. (Pubitemid 36109714)
29. Jonkers J, Moolenaar WH (2009). Mammary tumorigenesis through LPA receptor signaling. Canc Cell. 15: 457-459.
30. Kamrava M, Simpkins F, Alejandro E, Michener C, Meltzer E, Kohn EC (2005). Lysophosphatidic acid and endothelininduced proliferation of ovarian cancer cell lines is mitigated by neutralization of granulin-epithelin precursor (GEP), a prosurvival factor for ovarian cancer. Oncogene. 24: 7084-7093. (Pubitemid 41573637)
31. Kim WE, Serrero G (2006). PC cell-derived growth factor stimulates proliferation and confers Trastuzumab resistance to Her-2-overexpressing breast cancer cells. Clin Canc Res. 12: 4192-4199.
32. Kitayama J, Shida D, Sako A, Ishikawa M, Hama K, Aoki J, Arai H, Nagawa H (2004). Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma. Breast Canc Res. 6: R640-R646.
33. Kojima Y, Ono K, Inoue K, TakagiY, KikutaK, Nishimura M, Yoshida Y, Nakashima Y, Matsumae H, Furukawa Y, Mikuni N, Nobuyoshi M, Kimura T, Kita T, Tanaka M (2009). Progranulin expression in advanced human atherosclerotic plaque. Atherosclerosis. 206: 102-108.
34. Komachi M, Tomura H, Malchinkhuu E, Tobo M, Mogi C, Yamada T, Kimura T, Kuwabara A, Ohta H, Im DS, Kurose H, Takeyoshi I, Sato K, Okajima F (2009). LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration ofpancreatc cancer cells in response to lysophosphatidic acid and malignant ascites. Carcinogenesis. 30: 457-465.
35. Li TT, Alemayehu M, Aziziyeh AI, Pape C, Pampillo M, Postovit LM, Mills GB, Babwah AV, Bhattacharya M (2009). Betaarrestin/ Ral signaling regulates lysophosphatidic acidmediated migration and invasion of human breast tumor cells. Mol Cancer Res. 7: 1064-1077.
36. Liu Y, Xi L, Liao G, Wang W, Tian X, Wang B, Chen G, Han Z, Wu M, Wang S, Zhou J, Xu G, Lu Y, Ma D (2007). Inhibition of PC cell-derived growth factor (PCDGF)/granulinepithelin precursor (GEP) decreased cell proliferation and invasion through downregulation of cyclin D and CDK4 and inactivation of MMP-2. BMC Canc. 7: 22.
37. Lv GM, Li P, Wang WD, Wang SK, Chen JF, Gong YL (2011). Lysophosphatidic acid (LPA) and endothelial differentiation gene (Edg) receptors in human pancreatic cancer. J Surg Oncol
38. Miyanishi M, Mandai M, Matsumura N, Yamaguchi K, Hamanishi J, Higuchi T, Takakura K, Fujii S (2007). Immortalized ovarian surface epithelial cells acquire tumorigenicity by Acrogranin gene overexpression. Oncol Rep. 17: 329-333.
39. Monami G, GonzalezEM, Hellman M, Gomella LG, Baffa R, Iozzo RV, Morrione A (2006). Proepithelin promotes migration and invasion of 5637 bladder cancer cells through the activation of ERK1/2 and the formation of a paxillin/ FAK/ERK complex. Cancer Res. 66: 7103-7110. (Pubitemid 44197687)
40. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, Speed T, Spellman PT, Devries S, Lapuk A, Wang NJ, Kuo WL, Stilwell JL, Pinkel D, Albertson DG, Waldman FM, Mccormick F, Dickson RB, Johnson MD, Lippman M, Ethier S, Gazdar A, Gray JW (2006). A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Canc Cell. 10: 515-527. (Pubitemid 44854747)
41. Ogata S, Morishige K, Sawada K, Hashimoto K, Mabuchi S, Kawase C, Ooyagi C, Sakata M, Kimura T (2009). Fasudil inhibits lysophosphatidic acid-induced invasiveness of human ovarian cancer cells. Int J Gynecol Canc. 19: 1473-1480.
42. Ong CH, Bateman A (2003). Progranulin (granulin-epithelin precursor, PC-cell derived growth factor, acrogranin) in proliferation and tumorigenesis. Histol Histopathol. 18: 1275-1288. (Pubitemid 37265028)
43. Ong CH, He Z, Kriazhev L, Shan X, Palfree RG, Bateman A (2006). Regulation of progranulin expression in myeloid cells. Am J Physiol Regul Integr Comp Physiol. 291: R1602-R1612. (Pubitemid 44904125)
44. Park SY, JeongKJ, Panupinthu N, Yu S, Lee J, Han JW, Kim JM, Lee JS, Kang J, Park CG, Mills GB, Lee HY (2011). Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression. Oncogene. 30: 1351-1359.
45. Parrill AL (2011). Lysophosphatidic acid receptor agonists and antagonists (WO2010051053). Expert Opin Ther Pat. 21:281-286.
46. Samadi N, Gaetano C, Goping IS, Brindley DN (2009). Autotaxin protects MCF-7 breast cancer and MDA-MB-435 melanoma cells against Taxol-induced apoptosis. Oncogene. 28: 1028-1039.
47. Seifert A, Rau S, Kullertz G, Fischer B, Santos AN (2009). TCDD induces cell migration via NFATc1/ATX-signaling in MCF-7 cells. Toxicol Lett. 184: 26-32.
48. Serrero G (2003). Autocrine growth factor revisited: PC-cellderived growth factor (progranulin), a critical player in breast cancer tumorigenesis. Biochem Biophys Res Commun. 308: 409-413. (Pubitemid 36945505)
49. Serrero G, Ioffe OB (2003). Expression of PC-cell-derived growth factor in benign and malignant human breast epithelium. Hum Pathol. 34: 1148-1154. (Pubitemid 37467000)
50. Shin KJ, Kim YL, Lee S, Kim DK, Ahn C, Chung J, Seong JY, Hwang JI (2009). Lysophosphatidic acid signaling through LPA receptor subtype 1 induces colony scattering of gastrointestinal cancer cells. J Cancer Res Clin Oncol. 135: 45-52.
51. Sliva D, Mason R, Xiao H, English D (2000). Enhancement of the migration of metastatic human breast cancer cells by phosphatidic acid. Biochem Biophys Res Comm. 268: 471-479. (Pubitemid 30119647)
52. Subik K, Lee JF, Baxter L, Strzepek T, Costello D, Crowley P, Xing L, Hung MC, Bonfi glio T, Hicks DG, Tang P (2010). The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines. Breast Canc (Auckl). 4: 35-41.
53. Tangkeangsirisin W, Hayashi J, Serrero G (2004). PC cell-derived growth factor mediates tamoxifen resistance and promotes tumor growth of human breast cancer cells. Cancer Res. 64: 1737-1743. (Pubitemid 38428696)
54. Tangkeangsirisin W, Serrero G (2004). PC cell-derived growth factor (PCDGF/GP88, progranulin) stimulates migration, invasiveness and VEGF expression in breast cancer cells. Carcinogenesis. 25: 1587-1592. (Pubitemid 39214300)
55. Tigyi G (2010). Aiming drug discovery at lysophosphatidic acid targets. Br J Pharmacol. 161: 241-270.
56. Tkaczuk KR, Yue B, Zhan M, Tait N, Yarlagadda L, Dai H, Serrero G (2011). Increased Circulating Level of the Survival Factor GP88 (Progranulin) in the Serum of Breast Cancer Patients When Compared to Healthy Subjects. Breast Canc Basic and Clin Res. 5: 155-162.
57. Tolkatchev D, Malik S, Vinogradova A, Wang P, Chen Z, Xu P, Bennett HP, Bateman A, Ni F (2008). Structure dissection of human progranulin identifi es well-fo lded granulin/epithelin modules with unique functional activities. Protein Sci. 17: 711-724. (Pubitemid 351480865)
58. Wang GL, Wen ZQ, Xu WP, Wang ZY, Du XL, Wang F (2008). Inhibition of lysophosphatidic acid receptor-2 expression by RNA interference decreases lysophosphatidic acid-induced urokinase plasminogen activator activation, cell invasion, and migration in ovarian cancer SKOV-3 cells. Croat Med J. 49: 175-181. (Pubitemid 351669457)
59. Yun CC, Sun H, Wang D, Rusovici R, Castleberry A, Hall RA, Shim H (2005). LPA2 receptor mediates mitogenic signals in human colon cancer cells. Am J Physiol Cell Physiol. 289: C2-C11. (Pubitemid 40880819)
60. Zhang H, Serrero G (1998). Inhibition of tumorigenicity of the teratoma PC cell line by transfection with antisense cDNA for PC cell-derived growth factor (PCDGF, epithelin/granulin precursor). Proc Natl Acad Sci U S A. 95: 14202-14207. (Pubitemid 28549345)
61. Zhu L, Lee HO, Jordan CS, Cantrell VA, Southard-Smith EM, Shin MK (2004). Spatiotemporal regulation of endothelin receptor-B by SOX10 in neural crest-derived enteric neuron precursors. Nat Genet. 36: 732-737. (Pubitemid 38886635)